Wade D. Miquelon’s Fortune 50 CFO Experience Strengthens Acadia Healthcare Board
Wade D. Miquelon joined Acadia Healthcare’s board of directors in January 2012, bringing extensive financial leadership experience from Fortune 50 companies to the behavioral health provider’s governance structure. His tenure as executive vice president, chief financial officer, and president of international at Walgreens positioned him to contribute strategic financial oversight for Acadia Healthcare’s operations across 260 facilities in 40 states and Puerto Rico.
Miquelon served at Walgreens from 2008 to 2014, overseeing strategy, mergers and acquisitions, investor relations, business development, and risk management for the Chicago-based retailer with $72 billion in annual sales. His responsibilities included leading major acquisitions such as Drugstore.com and Duane Reade drugstore chain, alongside managing the complex two-step transaction to acquire and merge with Alliance Boots. This transactional experience applies to Acadia Healthcare’s growth strategy involving facility acquisitions and joint venture partnerships with health systems.
Financial reporting and regulatory compliance formed core aspects of Miquelon’s Walgreens role. Institutional Investor named him CFO of the year in 2011, while The Wall Street Journal placed him among its top nine CFOs to watch in 2012. These recognitions reflected his capabilities managing complex financial structures at a publicly traded retail healthcare company—skills directly transferable to behavioral healthcare company board oversight.
Prior to Walgreens, Miquelon served as executive vice president and CFO at Tyson Foods from 2006 to 2008, managing finances for the world’s largest meat and food service company with $30 billion in annual sales. His Tyson tenure provided additional experience with operational complexity, supply chain management, and margin pressures similar to challenges facing healthcare providers managing multiple facilities with varying payer mix and reimbursement rates.
Acadia Healthcare operates as a publicly traded company requiring sophisticated financial management, capital allocation strategies, and investor relations capabilities. Miquelon’s background managing finance functions at major corporations positions him to contribute board-level oversight for financial reporting, debt financing, capital expenditures, and strategic investments supporting the behavioral health network’s expansion objectives.
His board service since 2012 spans multiple Acadia Healthcare leadership transitions and strategic initiatives, providing institutional knowledge about the company’s financial evolution alongside contemporary expertise from concurrent retail industry experience managing Jo-Ann Stores as president and CEO through 2023.